| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
E2F transcription factor 7 | 0.678 | 0.346 | 0.99 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
dual specificity phosphatase 3 | 0.705 | 0.308 | 0.46 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2011 | ||||||||
|
preferentially expressed antigen in melanoma | 0.531 | 0.577 | 2.4E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
phosphoglycerate dehydrogenase | 0.484 | 0.885 | 1.3E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2018 | ||||||||
|
gastric inhibitory polypeptide receptor | 0.670 | 0.538 | 2.0E-29 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2017 | ||||||||
|
phosphoserine aminotransferase 1 | 0.478 | 0.846 | 1.1E-08 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2019 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2000 | 2018 | ||||||||
|
microRNA 346 | 0.631 | 0.615 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
metallothionein 3 | 0.582 | 0.615 | 6.4E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
neuronatin | 0.633 | 0.538 | 0.40 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
peroxiredoxin 1 | 0.485 | 0.846 | 7.7E-10 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2006 | 2008 | ||||||||
|
ERGIC and golgi 3 | 0.805 | 0.115 | 2.2E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2016 | ||||||||
|
selenoprotein S | 0.628 | 0.615 | 1.4E-09 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
syndecan 4 | 0.603 | 0.615 | 4.1E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2012 | 2018 | ||||||||
|
synaptophysin | 0.481 | 0.808 | 0.92 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2012 | ||||||||
|
E2F transcription factor 8 | 0.674 | 0.423 | 0.82 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2018 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 | 0.555 | 0.654 | 0.72 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2019 | ||||||||
|
xyloside xylosyltransferase 1 | 0.780 | 0.231 | 1.3E-03 |
|
disease | 0.110 | None | 0.500 | 1 | 0 | 2010 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily A member 6 | 0.556 | 0.731 | 5.4E-09 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
calcium/calmodulin dependent protein kinase II delta | 0.743 | 0.308 | 2.3E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2010 | ||||||||
|
kinesin family member 14 | 0.578 | 0.654 | 4.1E-05 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
acyl-CoA thioesterase 8 | 0.769 | 0.500 | 6.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cadherin 3 | 0.560 | 0.615 | 2.8E-10 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 |